We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
AUM
$143M
AUM Growth
+$17.2M
Cap. Flow
+$2.03M
Cap. Flow %
1.42%
Top 10 Hldgs %
32.26%
Holding
996
New
133
Increased
222
Reduced
163
Closed
42

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$1.87M
2
GS icon
Goldman Sachs
GS
+$1.4M
3
IRBT
iRobot
IRBT
+$1.1M
4
AMAT icon
Applied Materials
AMAT
+$965K
5
EVR icon
Evercore
EVR
+$867K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$1.43M
2
CL icon
Colgate-Palmolive
CL
+$1.03M
3
CAH icon
Cardinal Health
CAH
+$1M
4
NXPI icon
NXP Semiconductors
NXPI
+$807K
5
ALGN icon
Align Technology
ALGN
+$791K

Sector Composition

Rank Sector Weight
1 Technology 22.63%
2 Healthcare 11.54%
3 Financials 11.13%
4 Industrials 6.13%
5 Consumer Staples 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLR icon
26
Digital Realty Trust
DLR
$66.4B
$1.38M 0.97%
13,124
+120
+0.9% +$12.7K
CME icon
27
CME Group
CME
$91.9B
$1.38M 0.97%
8,547
+213
+3% +$33.9K
CBRL icon
28
Cracker Barrel
CBRL
$1.16B
$1.37M 0.96%
8,620
+415
+5% +$68.8K
KO icon
29
Coca-Cola
KO
$349B
$1.37M 0.96%
31,448
-872
-3% -$39.2K
XOM icon
30
ExxonMobil
XOM
$650B
$1.29M 0.9%
17,296
TMO icon
31
Thermo Fisher Scientific
TMO
$213B
$1.25M 0.88%
6,049
+234
+4% +$49.1K
BMY icon
32
Bristol-Myers Squibb
BMY
$126B
$1.21M 0.85%
19,148
+3,535
+23% +$227K
MRSH
33
Marsh
MRSH
$84.2B
$1.18M 0.83%
14,301
SPY icon
34
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$1.14M 0.8%
4,325
+10
+0.2% +$2.73K
ALGN icon
35
Align Technology
ALGN
$12B
$1.05M 0.74%
4,202
-3,082
-42% -$791K
ASML icon
36
ASML
ASML
$693B
$1.04M 0.73%
5,247
+703
+15% +$138K
PANW icon
37
Palo Alto Networks
PANW
$265B
$1.04M 0.73%
34,314
+2,658
+8% +$73.8K
AGO icon
38
Assured Guaranty
AGO
$3.73B
$1.03M 0.72%
28,486
+325
+1% +$11.5K
AMAT icon
39
Applied Materials
AMAT
$447B
$1.01M 0.71%
18,173
+17,340
+2,082% +$965K
FTNT icon
40
Fortinet
FTNT
$111B
$1.01M 0.7%
93,835
+5,160
+6% +$50.3K
CBM
41
DELISTED
Cambrex Corporation
CBM
$974K 0.68%
18,615
+1,640
+10% +$87.7K
AVGO icon
42
Broadcom
AVGO
$1.87T
$957K 0.67%
40,630
+4,050
+11% +$102K
DHR icon
43
Danaher
DHR
$135B
$957K 0.67%
11,025
+4,456
+68% +$390K
BBN icon
44
BlackRock Taxable Municipal Bond Trust
BBN
$970M
$953K 0.67%
42,333
+3,700
+10% +$82.4K
IRBT
45
DELISTED
iRobot
IRBT
$936K 0.66%
+14,580
New +$1.1M
FTV icon
46
Fortive
FTV
$18.5B
$932K 0.65%
19,059
+1,849
+11% +$88K
IJK icon
47
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$921K 0.65%
16,868
-92
-0.5% -$5.09K
LOW icon
48
Lowe's Companies
LOW
$113B
$916K 0.64%
10,435
EQIX icon
49
Equinix
EQIX
$102B
$909K 0.64%
2,175
+150
+7% +$63.1K
PSX icon
50
Phillips 66
PSX
$83B
$902K 0.63%
9,405
+25
+0.3% +$2.43K

Similar funds

Front Row Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Front Row Advisors held 996 positions worth $143M, up 14% from $126M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Front Row Advisors's Q1 2018 filing shows 133 new, 222 increased, 163 reduced and 42 closed positions. Its largest new stake was iRobot: 14,580 shares worth $936K. The largest sale was 3M, an estimated $1.43M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Front Row Advisors's largest Q1 2018 buy was iRobot: 14,580 shares worth $936K.
  • Front Row Advisors added most to Emerson Electric in Q1 2018, an estimated $1.87M increase.
  • Front Row Advisors's biggest Q1 2018 reduction was 3M, cutting an estimated $1.43M.
  • Front Row Advisors fully exited Cardinal Health in Q1 2018, selling an estimated $1M.
  • Front Row Advisors's ten largest holdings make up 32% of its $143M portfolio in Q1 2018.
  • Front Row Advisors opened 133 new positions and closed 42 in Q1 2018.
  • Front Row Advisors's portfolio value rose 14% quarter-over-quarter to $143M.

Based on Front Row Advisors's 13F filing for Q1 2018, filed 21 May 2018.